Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ProMIS Neurosciences Inc
PMN
Healthcare
Biotechnology
ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine...
applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PMN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 18, 2024 4:17pm
@ the Bell: TSX keeps it just above the flatline
Driven by materials stocks tracking higher metals prices, utilities led gainers on the TSX while energy and industrials led the drop.
read article.
(104)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Apr 18, 2024 11:35am
RE:Phase 1A
Yeah but 1b is where efficacy starts so until then it might as well be homeopathy.
Addition Of New Copper Claims at Topley Project
posted Apr 19, 2024 9:00am by
Geologica Resource Corp.
-
|
Geologica’s Topley Property is located in British Columbia, a global leader in the development of socially and environmentally responsible resources. Combined with a positive market sentiment for commodities like gold, silver, copper and molybdenum, Topley and Geologica are well-positioned to create significant value for shareholders ...read more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 18, 2024 5:00am
Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions
Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.
read article.
(79)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on Apr 17, 2024 5:37pm
Phase 1A
If they do a cheap financing before positive results from the 1A study then the entire board is negligent and self centered. Look at Acumen, did a financing at a high amount for less shares, not like
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 17, 2024 4:19pm
@ the Bell: TSX sees first positive day in a week
Canadian stock markets moved up on Wednesday as investors await fresh cues about timing of this year’s interest rate cuts
read article.
(79)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on Apr 17, 2024 2:26pm
Smells
Smells like another manipulated financing in the works. They never get this right and always do cheap financings , rather than reporting good news. What's Up!!!!!
(38)
•••
BottomBroker
X
View Profile
View Bullboard History
Comment by
BottomBroker
on Apr 17, 2024 10:05am
RE:Manipulation
Even the doubters must see by now the manipulation taking place here. I mean, last week there was a stready climb to around $2.50 and then whamo!, right back down to sub $2 on Monday via a 30
...more
(104)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Apr 15, 2024 3:24pm
RE:Manipulation
If they didn't want the bump on investor show wouldn't they just have kept Gail?
(79)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on Apr 15, 2024 2:38pm
Manipulation
Wow someone is playing games and wants a lot of cheap shares, guess who?
(104)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Apr 15, 2024 1:17pm
RE:Down 30%?
Just a reminder how thin the market really is, and therefore how easy control remains.
(38)
•••
BottomBroker
X
View Profile
View Bullboard History
Post by
BottomBroker
on Apr 15, 2024 9:46am
Down 30%?
Huh? Did something happen?
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 09, 2024 7:00am
New Press Release - ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS
Study results support ProMIS’ TDP-43 misfolding-specific epitope as a potential therapeutic target for Amyotrophic Lateral Sclerosis (ALS) CAMBRIDGE, Massachusetts and TORONTO, Ontario, April 09, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc.(Nasdaq: PMN), a biotechnology company focused on...
read article.
(104)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Apr 05, 2024 5:01pm
RE:False Hope
A competent CEO? What will we talk about?
(27)
•••
bball67
X
View Profile
View Bullboard History
Post by
bball67
on Apr 05, 2024 2:19pm
False Hope
Doing three conferences in a short period of time works for me. Earning his paycheck. As a CFO, I did maybe 50 with our CEO over an 11 year period. I saw what could happen, especially in the
...more
(116)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Apr 04, 2024 10:11am
RE:New Press Release - ProMIS Neurosciences to Present in Upcoming Investor Conferences in April
"Bloom Burton & Co. Healthcare Investor Conference (Toronto, Canada)" Ya, more false hope for Canadian Biotech startups! jmo G1945V
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 04, 2024 7:00am
New Press Release - ProMIS Neurosciences to Present in Upcoming Investor Conferences in April
CAMBRIDGE, Massachusetts and TORONTO, Ontario, April 04, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, today announced that...
read article.
(79)
•••
Gbathat
X
View Profile
View Bullboard History
Comment by
Gbathat
on Apr 02, 2024 8:33pm
RE:RE:annual numbers
lol, yes it does. and I don't mind being called out. I'll be right someday, maybe, lol.
(38)
•••
BottomBroker
X
View Profile
View Bullboard History
Comment by
BottomBroker
on Apr 02, 2024 12:58pm
RE:annual numbers
Man, if I had a nickle for every time I've heard that "this year will be an exciting year"... And I'm not calling you out, Gbathat. I've said it myself. Oh well, hope
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
The Increasing Investments by the Defense and Military Sectors is Driving the Demand for Helium
Positive PEA for Uranium-Vanadium Deposit After-tax NPV 8%: $227.7 million with IRR: 38.9%
Fokus Mining Welcomes Luc Gervais To Its Board Of Directors